Avantor, Inc. provides products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries worldwide.
Avantor stock last closed at $25.13, down 1.61% from the previous day, and has increased 22.35% in one year. It has overperformed other stocks in the Specialty Chemicals industry by 0.07 percentage points. Avantor stock is currently +51.11% from its 52-week low of $16.63, and -10.25% from its 52-week high of $28.00.
At the moment, there are 679.84M AVTR shares outstanding. The market value of AVTR is $17.08B. In the past 24 hours, 2.95M AVTR shares were traded.
You need a brokerage account to access the NYSE market and buy AVTR shares.
Based on our analysis, eToro is the best brokerage. Here's why:
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountNow that you've chosen the right brokerage, you need to fill out some personal information so you can invest in AVTR today.
Now that you've finished signing up on apps for stock market, you need to deposit funds:
Check out the video below if you need help transferring money into your new brokerage account.
Once you have identified the best place to buy Avantor stock, it's important to evaluate their stock before you invest, so you can comprehend the risk and opportunity.
WallStreetZen was created to help part-time investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on AVTR's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge AVTR's intrinsic value.
Using relative valuations ratios:
You can do additional valuation analysis on AVTR's stock here.
Out of 10 Wall Street analysts who give recommendations on AVTR, the consensus analyst rating on Avantor is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Daniel Arias, a top 17% analyst from Stifel Nicolaus maintains AVTR with a strong buy rating and raises their AVTR price target from $27.00 to $28.00, on Jul 29, 2024.
Stifel Nicolaus's Daniel Arias raised their price target on Avantor (NYSE: AVTR) by 3.7% from $27 to $28 on 2024/07/29. The analyst maintained their Strong Buy rating on the stock.
Avantor beat expectations while management maintained its FY guidance, Arias summed up after reviewing Avantor's Q2 2024 print released on 2024/07/26.
According to the analyst, the post-print Street reaction was robust, although slightly exaggerated, considering "the math of the guide."
Nonetheless, Arias noted that "a key sentiment" at the moment is rebounding optimism on a relatively inexpensive stock.
For Q2 2024, Avantor reported:
Management reiterated its FY 2024 guidance.
President & CEO Michael Stubblefield commented: "Improved mix from increased bioprocessing revenue together with the accelerated impact of our cost transformation initiative drove more than 100 bps of Q/Q Adjusted EBITDA margin expansion, while disciplined working capital management led to free cash flow conversion above 100%.
"We are reaffirming our FY 2024 guidance and remain focused on executing our long-term growth strategy and delivering value to our customers and shareholders."
Catherine Schulte, a top 6% analyst from Baird maintains AVTR with a buy rating and raises their AVTR price target from $26.00 to $27.00, on Jul 29, 2024.
Patrick B Donnelly, a top 13% analyst from Citigroup downgrades AVTR to a hold rating and lowers their AVTR price target from $30.00 to $23.00, on Jul 10, 2024.
Vijay Kumar, a bottom 10% analyst from Evercore ISI Group maintains AVTR with a buy rating and lowers their AVTR price target from $28.00 to $27.00, on Jul 2, 2024.
Justin Bowers, a bottom 9% analyst from Deutsche Bank maintains AVTR with a hold rating and raises their AVTR price target from $23.00 to $25.00, on Apr 18, 2024.
You can dive deeper into what analysts are forecasting on the Avantor stock forecast page.
Last year, AVTR earnings were $360.20M. In the past 4 year, AVTR's earnings have gone up by 5.86% per year. This was faster than the Specialty Chemicals industry average of 5.2%.
Last year, AVTR revenue was $6.83B. During the last five year, AVTR's revenue has grown by 2.68% per year. This was slower than the Specialty Chemicals industry average of 5.76%.
Find out more about AVTR's earnings and revenue performance here.
Over the last 12 months, insiders at AVTR have sold more shares than they have bought.
Steven W. Eck, SVP Chief Accounting Officer of AVTR, was the latest AVTR insider to sell. They sold $88,336.50 worth of AVTR stock on Sep 5, 2024.
Research more about who owns AVTR stock here.
No, Avantor doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
You have two primary order types:
Press the Open Trade button and your broker will place the order.
If you want more help with buying stocks on eToro, watch the how to video below:
Now that you own some AVTR stock, you'll want to keep up with your investment.
Create a watchlist to keep track of your AVTR stock.
To summarize, here are the 6 steps for buying Avantor stock:
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep track of your investment in Avantor, click below.